These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 32511132)
1. Latency-associated Peptide Identifies Immunoevasive Subtype Gastric Cancer With Poor Prognosis and Inferior Chemotherapeutic Responsiveness. Cao Y; He H; Li R; Liu X; Chen Y; Qi Y; Yu K; Wang J; Lin C; Liu H; Zhang H; Li H; Chen L; Zhang P; Shen Z; Huang H; Sun Y; Zhang W; Qin J; Xu J Ann Surg; 2022 Jan; 275(1):e163-e173. PubMed ID: 32511132 [TBL] [Abstract][Full Text] [Related]
2. Intratumoral Foxp3 Fei Y; Cao Y; Gu Y; Fang H; Chen Y; Wang J; Liu X; Lv K; He X; Lin C; Liu H; Li H; He H; Li R; Zhang H; Zhang W Cancer Immunol Immunother; 2022 Jan; 71(1):1-11. PubMed ID: 33978826 [TBL] [Abstract][Full Text] [Related]
3. Poor Clinical Outcomes and Immunoevasive Contexture in Intratumoral IL-10-Producing Macrophages Enriched Gastric Cancer Patients. Zhang H; Li R; Cao Y; Gu Y; Lin C; Liu X; Lv K; He X; Fang H; Jin K; Fei Y; Chen Y; Wang J; Liu H; Li H; Zhang H; He H; Zhang W Ann Surg; 2022 Apr; 275(4):e626-e635. PubMed ID: 32541216 [TBL] [Abstract][Full Text] [Related]
4. Poor clinical outcomes of intratumoral dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin-positive macrophages associated with immune evasion in gastric cancer. Liu X; Cao Y; Li R; Gu Y; Chen Y; Qi Y; Lv K; Wang J; Yu K; Lin C; Liu H; Zhang H; He H; Chen L; Zhang P; Shen Z; Qin J; Sun Y; Li H; Huang H; Zhang W; Xu J Eur J Cancer; 2020 Mar; 128():27-37. PubMed ID: 32109848 [TBL] [Abstract][Full Text] [Related]
5. Latency-associated peptide identifies therapeutically resistant muscle-invasive bladder cancer with poor prognosis. Ye R; Zeng H; Liu Z; Jin K; Liu C; Yan S; Yu Y; You R; Zhang H; Chang Y; Wang Y; Liu L; Zhu Y; Xu J; Xu L; Wang Z Cancer Immunol Immunother; 2022 Feb; 71(2):301-310. PubMed ID: 34152439 [TBL] [Abstract][Full Text] [Related]
6. Tumor-infiltrating podoplanin Liu X; Cao Y; Lv K; Gu Y; Jin K; He X; Fang H; Fei Y; Shi M; Lin C; Liu H; Li H; He H; Xu J; Li R; Zhang H Oncoimmunology; 2020 Nov; 9(1):1845038. PubMed ID: 33235820 [TBL] [Abstract][Full Text] [Related]
7. Poor clinical outcomes and immunoevasive contexture in CXCL13+CD8+ T cells enriched gastric cancer patients. Jin K; Cao Y; Gu Y; Fang H; Fei Y; Wang J; Liu X; Lv K; He X; Lin C; Liu H; Li H; He H; Li R; Zhang H; Xu J Oncoimmunology; 2021 Apr; 10(1):1915560. PubMed ID: 33996266 [TBL] [Abstract][Full Text] [Related]
8. Intratumoral CD103 Gu Y; Chen Y; Jin K; Cao Y; Liu X; Lv K; He X; Lin C; Liu H; Li H; He H; Qin J; Li R; Zhang H; Zhang W Oncoimmunology; 2020 Nov; 9(1):1844402. PubMed ID: 33312758 [TBL] [Abstract][Full Text] [Related]
9. TIM3 Chen K; Gu Y; Cao Y; Fang H; Lv K; Liu X; He X; Wang J; Lin C; Liu H; Zhang H; He H; Xu J; Li H; Li R Br J Cancer; 2022 Jan; 126(1):100-108. PubMed ID: 34725458 [TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes and Immune Metrics in Intratumoral Basophil-Enriched Gastric Cancer Patients. He X; Cao Y; Gu Y; Fang H; Wang J; Liu X; Lv K; Yu K; Fei Y; Lin C; Liu H; Zhang H; Li H; Xu J; Li R; He H Ann Surg Oncol; 2021 Oct; 28(11):6439-6450. PubMed ID: 33738713 [TBL] [Abstract][Full Text] [Related]
11. Intratumoral CXCL13 Dai S; Zeng H; Liu Z; Jin K; Jiang W; Wang Z; Lin Z; Xiong Y; Wang J; Chang Y; Bai Q; Xia Y; Liu L; Zhu Y; Xu L; Qu Y; Guo J; Xu J J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33589528 [TBL] [Abstract][Full Text] [Related]
12. Impact of intratumoural CD96 expression on clinical outcome and therapeutic benefit in gastric cancer. Xu C; Fang H; Gu Y; Yu K; Wang J; Lin C; Zhang H; Li H; He H; Liu H; Li R Cancer Sci; 2022 Dec; 113(12):4070-4081. PubMed ID: 35997524 [TBL] [Abstract][Full Text] [Related]
13. Intratumoral IL22-producing cells define immunoevasive subtype muscle-invasive bladder cancer with poor prognosis and superior nivolumab responses. Zeng H; Liu Z; Wang Z; Zhou Q; Qi Y; Chen Y; Chen L; Zhang P; Wang J; Chang Y; Bai Q; Xia Y; Wang Y; Liu L; Zhu Y; Dai B; Guo J; Xu L; Zhang W; Xu J Int J Cancer; 2020 Jan; 146(2):542-552. PubMed ID: 31584197 [TBL] [Abstract][Full Text] [Related]
14. Impact of intratumoural CD73 expression on prognosis and therapeutic response in patients with gastric cancer. He X; Gu Y; Cao Y; Hu B; Fang H; Fei Y; Lv K; Liu X; Wang J; Lin C; Liu H; Zhang H; Li H; Li R; He H; Xu J Eur J Cancer; 2021 Nov; 157():114-123. PubMed ID: 34508993 [TBL] [Abstract][Full Text] [Related]
15. Up-regulated Wnt1-inducible signaling pathway protein 1 correlates with poor prognosis and drug resistance by reducing DNA repair in gastric cancer. Zhang LH; Wang Y; Fan QQ; Liu YK; Li LH; Qi XW; Mao Y; Hua D World J Gastroenterol; 2019 Oct; 25(38):5814-5825. PubMed ID: 31636474 [TBL] [Abstract][Full Text] [Related]
16. Lymphocyte-activation gene 3 expression associates with poor prognosis and immunoevasive contexture in Epstein-Barr virus-positive and MLH1-defective gastric cancer patients. Lv K; Li R; Cao Y; Gu Y; Liu X; He X; Jin K; Fang H; Fei Y; Shi M; Liu H; Li H; He H; Lin C; Zhang H; Xu J Int J Cancer; 2021 Feb; 148(3):759-768. PubMed ID: 33105024 [TBL] [Abstract][Full Text] [Related]
17. Immune inactivation by VISTA predicts clinical outcome and therapeutic benefit in muscle-invasive bladder cancer. Li W; Liu Z; Jin K; Shao F; Zeng H; Wang Y; Zhu Y; Xu L; Wang Z; Chang Y; Zhang W BMC Cancer; 2023 Jul; 23(1):661. PubMed ID: 37452272 [TBL] [Abstract][Full Text] [Related]
18. CD47 expression in gastric cancer clinical correlates and association with macrophage infiltration. Shi M; Gu Y; Jin K; Fang H; Chen Y; Cao Y; Liu X; Lv K; He X; Lin C; Liu H; Li H; He H; Qin J; Li R; Zhang H; Zhang W Cancer Immunol Immunother; 2021 Jul; 70(7):1831-1840. PubMed ID: 33389016 [TBL] [Abstract][Full Text] [Related]
19. Tumor-associated macrophages expressing galectin-9 identify immunoevasive subtype muscle-invasive bladder cancer with poor prognosis but favorable adjuvant chemotherapeutic response. Qi Y; Chang Y; Wang Z; Chen L; Kong Y; Zhang P; Liu Z; Zhou Q; Chen Y; Wang J; Bai Q; Xia Y; Liu L; Zhu Y; Xu L; Dai B; Guo J; Wang Y; Xu J; Zhang W Cancer Immunol Immunother; 2019 Dec; 68(12):2067-2080. PubMed ID: 31720813 [TBL] [Abstract][Full Text] [Related]
20. Immune inactivation by APOBEC3B enrichment predicts response to chemotherapy and survival in gastric cancer. Xia S; Gu Y; Zhang H; Fei Y; Cao Y; Fang H; Wang J; Lin C; Zhang H; Li H; He H; Xu J; Li R; Liu H; Zhang W Oncoimmunology; 2021; 10(1):1975386. PubMed ID: 34552824 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]